"Stop Early Age-related Macular Degeneration (AMD) From Vision Loss Eternally" Study

• Status: Unknown status
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study aims to validate the efficacy and safety of subthreshold laser photocoagulation on high-risk macular drusen in early age-related macular degeneration which has a high risk of conversion to exudative AMD.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Bundang Hospital
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

• Drusen in both eyes examined under fundoscopy

• At least one of the eyes must have high-risk soft drusen

• BCVA below ETDRS 83 letters

• Patient with consent to participate

Exclusion Criteria:

• Prior diagnosis with choroidal neovascularization

• Exudative AMD in at least one eye

• If the patient has only one visually effective eye (last eye)

• Other macula or retinal diseases than age-related macular degeneration